Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

614 V. TREATMENTS FOR ADDICTIONSadone maintenance: Rate of withdrawal and expectation. Arch Gen Psychiatry, 34,361–367.Silva de Lima, M., Garcia de Olivereiro Soares, B., Alves Pereira Reisser, A., & Farrell,M. (2002). Pharmacological treatment of cocaine dependence: A systematicreview. Addiction, 97, 931–949.Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., & Sellers, E. M. (1989).Assessment of alcohol withdrawal: The revised Clinical Institute WithdrawalInstrument for Alcohol Scale (CIWA-Ar). Br J Addict, 84, 1353–1357.Van den Brink, W., Goppel, M., & van Ree, J. M. (2003). Management of opioiddependence. Curr Opin in Psychiatry, 16, 297–304.Vining, E., Kosten, T. R., & Kleber, H. D. (1988). Clinical utility of rapid clonidinenaltrexone detoxification for opioid abusers. Br J Addict, 83, 567–575.Volpicelli, J., Alterman, A. I., O’Brien, C. P., & Hayashida, M. (1992). Naltrexone inthe treatment of alcohol dependence. Arch Gen Psychiatry, 49, 867–880.Volpicelli, J., Rhines, K., & Rhines, J. (1997). Naltrexone and alcohol dependence:Role of subject compliance. Arch Gen Psychiatry, 54, 737–742.Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994). Clinicalpharmacology of buprenorphine: Ceiling effects at high doses. Clin PharmacolTher, 55, 569–580.Wilde, M. I., & Wagstaff, A. J. (1997). Acamprosate: A review of its pharmacology andclinical potential in the management of alcohol dependence after detoxification.Drugs, 53, 1038–1053.Wright, C., & Moore, R. D. (1990). Disulfiram treatment of alcoholism. Am J Med, 88,647–655.Zeise, M. L., Kasparov, S., Capogna, M., & Zieglgansberger, W. (1993). Acamprosate(calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex:Possible involvement of excitatory amino acid receptors. Eur J Pharmacol, 231,47–52.